Q1 Rundown: Anheuser-Busch (NYSE:BUD) Vs Other Beverages, Alcohol, and Tobacco Stocks
BUD Cover Image
Q1 Rundown: Anheuser-Busch (NYSE:BUD) Vs Other Beverages, Alcohol, and Tobacco Stocks

In This Article:

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the beverages, alcohol, and tobacco industry, including Anheuser-Busch (NYSE:BUD) and its peers.

These companies' performance is influenced by brand strength, marketing strategies, and shifts in consumer preferences. Changing consumption patterns are particularly relevant and can be seen in the rise of cannabis, craft beer, and vaping or the steady decline of soda and cigarettes. Companies that spend on innovation to meet consumers where they are with regards to trends can reap huge demand benefits while those who ignore trends can see stagnant volumes. Finally, with the advent of the social media, the cost of starting a brand from scratch is much lower, meaning that new entrants can chip away at the market shares of established players.

The 15 beverages, alcohol, and tobacco stocks we track reported a mixed Q1. As a group, revenues missed analysts’ consensus estimates by 0.5%.

In light of this news, share prices of the companies have held steady as they are up 2.1% on average since the latest earnings results.

Anheuser-Busch (NYSE:BUD)

Born out of a complicated web of mergers and acquisitions, Anheuser-Busch InBev (NYSE:BUD) boasts a powerhouse beer portfolio of Budweiser, Stella Artois, Corona, and local favorites around the world.

Anheuser-Busch reported revenues of $13.63 billion, down 6.3% year on year. This print fell short of analysts’ expectations by 1.3%. Overall, it was a softer quarter for the company with a significant miss of analysts’ EPS estimates.

Anheuser-Busch Total Revenue
Anheuser-Busch Total Revenue

The market was likely pricing in the results, and the stock is flat since reporting. It currently trades at $65.99.

Is now the time to buy Anheuser-Busch? Access our full analysis of the earnings results here, it’s free.

Best Q1: Zevia (NYSE:ZVIA)

With a primary focus on soda but also a presence in energy drinks and teas, Zevia (NYSE:ZVIA) is a better-for-you beverage company.

Zevia reported revenues of $38.02 million, down 2% year on year, outperforming analysts’ expectations by 1.7%. The business had a very strong quarter with a solid beat of analysts’ EBITDA estimates and an impressive beat of analysts’ EPS estimates.

Zevia Total Revenue
Zevia Total Revenue

The market seems happy with the results as the stock is up 39.7% since reporting. It currently trades at $2.85.

Is now the time to buy Zevia? Access our full analysis of the earnings results here, it’s free.

Slowest Q1: Celsius (NASDAQ:CELH)

With its proprietary MetaPlus formula as the basis for key products, Celsius (NASDAQ:CELH) offers energy drinks that feature natural ingredients to help in fitness and weight management.